Lilly, Roswell Park Cancer Institute Partner to Train Minority Clinical Trial Investigators
The partnership will include a three-day clinical research workshop, "Reducing Cancer Disparities Through the Training of a Diverse Workforce," for minority physicians across the country. Workshops will begin in spring 2014 and will run through 2016.
There are approximately 10,400 oncologists in
"Providing patients with access to new and innovative therapies is one of the most crucial issues in oncology," said workshop director
"Because medicines don't work the same for everyone, we need to understand how medicines work and the safety profile in patients likely to take them. By training more oncology minority investigators, our goal is to reach even more diverse populations," said Coleman Obasaju, M.D., Ph.D., senior medical director at Lilly Oncology and global leader of diversity in clinical research.
The goals of the workshop include:
- Enhancing clinical research in minority and underserved populations through development of a cadre of well-trained minority investigators;
- Educating participants about the principles of good clinical trial design and providing the necessary tools required to conduct trials that are relevant to minorities and under-represented populations;
- Guiding participants to identify various challenges of clinical research, particularly in minority and underserved populations, and providing advice and education on how to overcome these challenges;
- Providing ongoing mentorship to young minority investigators through career-long relationships with workshop faculty; and
- Reducing cancer health disparities through increased clinical research targeting minority and underserved populations.
Organizers are targeting minority physicians and senior fellows who have cancer-related sub-specialties in medical, hematologic, radiation, pediatric, surgical and gynecologic oncology. Faculty in the first five years of their academic appointments and those working full-time at an academic institution or practice with a track record of enrolling patients in cancer clinical trials may apply to participate in the workshop.
Enrollment for the 2014 workshop will begin this fall, with details about the application process to be posted on both the RPCI and Lilly websites.
About
The mission of
About
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in
|
|
Director, |
Senior Media Relations Manager |
|
|
317.612.4974 mobile |
716.845.8593 office |
716.602.5817 mobile | |
(Logo: http://photos.prnewswire.com/prnh/20130801/DE55694LOGO)
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)
SOURCE
News Provided by Acquire Media